Cybin And Small Pharma Shareholders Green Light Acquisition Resolution Clinical-stage psychedelics biotechs Canada-based Cybin Inc. (NYSE:CYBN) and UK-based Small Pharma Inc. (OTC:DMTTF) held their respective annual general and special shareholders meetings on October 12. They announced that voting results favored the arrangement plan for the latter's acquisition by the former. The TSX Venture Exchange conditionally approved the arrangement. Subject to the approval of BC's Supreme Court and other customary closing conditions, the arrangement's effective date would take place on or around October 23, 2023. Read more HERE. FDA Issues Warning Over Ketamine Misuse, DEA Extends
Psyched: FDA Warning, DEA's Telehealth Extension, CA Gov's Veto, Congress On Kratom, M&As & More
Benzinga · 10/17/2023 03:57
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.